Access

Business

Nature 436, 327 (21 July 2005) | doi:10.1038/436327a; Published online 20 July 2005

Open Innovation Challenges

In brief

US regulators have granted the maker of a promising influenza vaccine 'fast track' status in its licensing application — increasing the chances that it will be ready in time for the flu season after next. ID Biomedical of Vancouver, British Columbia, already supplies the injectable vaccine, called Fluviral, in Canada.